Unitree has priced its IPO on Shanghai’s Star Market at 150.8 yuan per share, aiming to raise 6.1 billion yuan. DeepSeek invested 141 million yuan and partnered to co-develop AI models.
Chinese start-up X Square Robot has confidentially filed for a Hong Kong IPO, tapping Huatai Securities and Morgan Stanley as sponsors amid a wave of domestic robotics listings.
AI firm Moonshot aims to raise capital at a valuation of up to US$50 billion in a pre-IPO funding round, following a US$30 billion valuation last month.
Jersey Mike's debuted on the New York Stock Exchange under ticker "JMKE," opening at $21, below its $23 IPO price, and closing down 6%. The IPO raised $1 billion, valuing the company at $7.3 billion, making it one of the largest restaurant IPO fundraises. The chain plans significant international expansion.
Ant Digital Technologies is preparing a pre-IPO financing round, while database developer OceanBase seeks external equity funding. These moves highlight Ant Group's strategy to build independent capital structures for its spun-off units after its 2020 aborted IPO.
Unitree Robotics, a Hangzhou-based firm, announced its initial public offering (IPO) on Shanghai's Star Market next week, planning to sell 40.45 million shares. This move is part of a broader trend among Chinese robotics start-ups racing to go public amidst intense rivalry with US counterparts.
An unnamed Shanghai-based company aims for an IPO by year-end, driven by Beijing's semiconductor self-reliance initiative amidst ongoing US export controls.
Beijing-based AI start-up Moonshot AI is set to close its current funding round at a US$30 billion valuation and plans a subsequent round as early as August, targeting up to US$50 billion before a potential listing, according to a source familiar with the matter.
AgiBot had eyed a Hong Kong listing this year, targeting a HK$40-50 billion valuation, with CICC and Morgan Stanley as potential joint sponsors. Separately, Innolight's IPO, aiming to raise US$8 billion, attracted over 30 cornerstone investors for a July 30 debut, potentially the city's biggest listing in seven years.
Axiom Biosciences, a US-based biotech firm developing AI-powered therapies for newborn brain injuries, is targeting a US$200 million initial public offering (IPO) in Hong Kong by 2027, with a secondary listing in the US planned for 2029. CEO Remo Moomiaie-Qajar highlighted Hong Kong's mature market for healthcare listings.
Investors showed overwhelming demand for China's CXMT IPO, a leading DRAM producer, submitting applications for nearly 817 billion shares. The high interest triggered a clawback mechanism, shifting shares to retail investors, highlighting appetite for domestic chip alternatives. Winning lottery numbers for allocations are due Monday.
CXMT, China's memory chip champion, attracts heavy investment in its IPO, promising a high allotment rate and potential fourfold gain amid the AI-driven market boom.
Semiconductor firm CXMT plans to raise 29.5 billion yuan ($4.4 billion) in its Shanghai IPO, with analysts predicting a potential market value of 3 trillion yuan. Founder Zhu's long-term vision for China's role in the memory chip industry is highlighted.
Online retail giant Shein has received approval from China's CSRC to pursue an IPO in Hong Kong, planning to issue up to 341.6 million shares. Previous IPO attempts in New York and London were stalled due to regulatory scrutiny.
A surge in wealth from AI startups and SpaceX has led to a significant increase in private jet purchases and charters. Tech investors, benefiting from IPOs and liquidity events, are channeling newfound wealth into private aviation, driving demand and sales for companies like Soar Aviation Law, Flexjet, and Jet Linx.
Chinese memory giant CXMT is proceeding with its Shanghai listing, with a share offering expected to raise at least $4.3 billion. This move positions CXMT as a key player challenging global leaders in the growing memory-chip market, driven by AI demand.
Hong Kong stocks fell Thursday, erasing earlier gains due to Asian market volatility and a tech sector slump. Knowledge Atlas Technology surged, while MiniMax tumbled. Regional markets like South Korea and Japan showed mixed signs.
Elon Musk's dismantling of USAID is under scrutiny amid the DRC Ebola outbreak, with experts linking the cuts to delayed detection and preparedness. Critics estimate millions of deaths could result, including children, if global health programs are slashed.
The CSRC's IPO approval process prioritizes industries "going global," such as AI, robotics, semiconductors, and biotech, making it easier for them to secure capital. Companies nearing a six-month deadline face application restarts if they fail listing hearings, though lapsed prospectuses don't signify failure if fundamentals remain strong.
Hong Kong's stock exchange secured second place globally in H1 2026 for capital raised, with $26.4 billion from IPOs and secondary listings, an 84.3% YoY increase. Mainland Chinese firms dominated, focusing on tech and consumer staples.
Reliance Jio plans a US$3.8-4 billion IPO, potentially India's largest, to retire debt. This move could spur other digital firms to raise funds, with market conditions stabilizing and improved global sentiment aiding IPO launches.
Basic, a Chinese SiC device manufacturer founded in 2016, prepares for its public debut, aligning with China's efforts to lead in SiC technology, despite current market oversupply, with anticipated demand growth driven by 800V architectures and data center adoption by 2027-2028.
Mainland Chinese investors bought a record HK$1.19 trillion (US$151.8 billion) in Hong Kong shares via Southbound Stock Connect in the past year, reflecting strong market confidence driven by a robust IPO pipeline. Average daily turnover of these inflows surged 84% year-on-year.
Two major Chinese MLCC suppliers, Chaozhou Three-Circle and Jiangsu Boqian New Materials, are pursuing Hong Kong listings to capitalize on surging global demand for MLCCs driven by AI infrastructure growth.
